How antimalarial drug resistance affects post-treatment prophylaxis
Open Access
- 11 January 2008
- journal article
- review article
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 9-7
- https://doi.org/10.1186/1475-2875-7-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Sulfadoxine-Pyrimethamine Resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During PregnancyJAMA, 2007
- Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed?Malaria Journal, 2007
- MATHEMATICAL MODEL OF THE FIRST WAVE OF PLASMODIUM FALCIPARUM ASEXUAL PARASITEMIA IN NON-IMMUNE AND VACCINATED INDIVIDUALSThe American Journal of Tropical Medicine and Hygiene, 2006
- Intermittent Presumptive Treatment for MalariaPLoS Medicine, 2005
- The origins of antimalarial drug resistanceTrends in Parasitology, 2004
- The assessment of antimalarial drug efficacyTrends in Parasitology, 2002
- The evolution of drug–resistant malaria: the role of drug elimination half–lifePhilosophical Transactions Of The Royal Society B-Biological Sciences, 2002
- Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infectionParasitology, 2002
- The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analysesParasitology Today, 1997
- Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-lifeTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993